Funds · LXEO

Who owns LXEO?

Institutional ownership of Lexeo Therapeutics Inc. from Form 13F, Q2 2026

142 institutional managers reported holding Lexeo Therapeutics Inc. (LXEO) in Form 13F filings for Q2 2026, with 89,540,530 shares worth $417M. The largest reported holder was Montanova Capital, LLC. Managers that filed both quarters added a net 10,690,612 shares (+14.3%). 27 opened new positions and 21 sold out.

Funds holding
142
Value held
$417M
New / sold out
27 / 21
Net shares, same filers
+14.3%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of LXEO

FundValueShare of 13F holdingsSharesMove
Montanova Capital, LLC$29.7M7.1%6,384,200Added
Affinity Asset Advisors, LLC$27.0M6.5%5,807,611Added
BlackRock, Inc.$26.7M6.4%5,739,455Added
Ra Capital Management, L.p.$23.3M5.6%5,000,000Unchanged
Frazier Life Sciences Management, L.P.$22.5M5.4%4,824,725Added
State Street Corp$20.3M4.9%4,354,757Added
Vestal Point Capital, LP$20.1M4.8%4,320,000Trimmed
Paradigm Biocapital Advisors LP$19.4M4.7%4,175,382Trimmed
Jupiter Topco LLC$18.4M4.4%3,954,691First report
Orbimed Advisors LLC$18.4M4.4%3,947,850Added
Citadel Advisors LLC$18.1M4.4%3,898,570Added
Vanguard Capital Management LLC$14.6M3.5%3,125,893Added
Millennium Management LLC$13.2M3.2%2,833,622Added
Nantahala Capital Management, LLC$12.1M2.9%2,600,000Added
Woodline Partners LP$11.6M2.8%2,500,532Trimmed
Balyasny Asset Management L.P.$11.2M2.7%2,412,742Added
Goldman Sachs Group Inc$10.0M2.4%2,149,612Added
683 Capital Management, LLC$8.7M2.1%1,875,000Added
Geode Capital Management, LLC$8.1M2.0%1,747,959Added
ADAR1 Capital Management, LLC$7.3M1.7%1,565,950Added
Avoro Capital Advisors LLC$6.9M1.7%1,489,189Trimmed
Qube Research & Technologies Ltd$6.4M1.5%1,376,222Added
Dimensional Fund Advisors LP$6.0M1.4%1,287,185Added
Spruce Street Capital LP$4.3M1.0%928,593Unchanged
Blackstone Inc.$4.2M1.0%904,959Unchanged

Share of 13F holdings is each fund's shares as a share of the 89,540,530 LXEO shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $80.4M and sold $34.3M; 58 added and 39 trimmed.

Schedule 13D and 13G filings on LXEO

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about LXEO ownership

Who owns LXEO stock?
142 institutional investment managers reported LXEO positions in their Form 13F filings for Q2 2026, holding 89,540,530 shares worth $417M in total. Montanova Capital, LLC reported the largest position.
Are funds buying or selling LXEO?
In Q2 2026, 27 managers opened new LXEO positions, 58 added, 39 trimmed and 21 sold out. Managers that filed in both quarters added a net 10,690,612 shares.
How current is this LXEO institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to LXEO by CUSIP. Options are left out. LXEO news and filings · LXEO insider trades · Top funds